Chronisch lymphatische Leukämie vom B-Zellen-Typ: Klinische und morphologische Untersuchungen zur diagnostischen Abgrenzung

Translated title of the contribution: Chronic lymphatic leukemia of B-cell type: Clinical and morphological investigations for diagnostic differentiation

J. D. Schwarzmeier, T. Radaszkiewicz, W. Graninger, F. Hofer, Elisabeth M. Paietta, Ch Moser

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Chronic lymphatic leukemia (CLL) was diagnosed in 71 patients based on clinical data. Most of the patients were in the stages 0, I and II, only 18% were in the stages III and IV according to Rai. In all cases, the disease was characterized by an increased number of B lymphocytes (B-CLL). The B cells mostly expressed a weak fluorescence intensity when tested for membrane bound immunoglobulins (Ig). In accordance to that, the quantitative measurement of Ig in the serum revealed a decrease of one or more Ig classes in 72% of the patients. No correlation existed between the number of B lymphocytes (and T lymphocytes) or the Ig concentration in the serum and the stage of the disease. To distinguish the CLL from related lymphoproliferative disorders, especially the immunocytic lymphoma, lymphnode biopsies were examined histologically and immunomorphologically for intracytoplasmic Ig. This examination confirmed the diagnosis of CLL in 33 out of 40 cases. Six lymphnodes were classified as immunocytic lymphoma of the lymphoplasmacytoid type. In three of the latter, the immunocytic lymphoma was clinically associated with decreased Ig concentrations in the serum. These findings emphasize that the clinically established diagnosis of CLL should be corroborated by immunomorphology.

Original languageGerman
Pages (from-to)1313-1318
Number of pages6
JournalKlinische Wochenschrift
Volume59
Issue number23
DOIs
StatePublished - Dec 1981
Externally publishedYes

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Immunoglobulins
Lymphoma
Serum
Waldenstrom Macroglobulinemia
B-Cell Antigen Receptors
Lymphoproliferative Disorders
Immunoglobulin Isotypes
Fluorescence
T-Lymphocytes
Biopsy

Keywords

  • B-cell proliferation
  • Chronic lymphatic leukemia
  • Hypogammaglobulinaemia
  • Immunocytic lymphoma
  • Immunomorphology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chronisch lymphatische Leukämie vom B-Zellen-Typ : Klinische und morphologische Untersuchungen zur diagnostischen Abgrenzung. / Schwarzmeier, J. D.; Radaszkiewicz, T.; Graninger, W.; Hofer, F.; Paietta, Elisabeth M.; Moser, Ch.

In: Klinische Wochenschrift, Vol. 59, No. 23, 12.1981, p. 1313-1318.

Research output: Contribution to journalArticle

Schwarzmeier, J. D. ; Radaszkiewicz, T. ; Graninger, W. ; Hofer, F. ; Paietta, Elisabeth M. ; Moser, Ch. / Chronisch lymphatische Leukämie vom B-Zellen-Typ : Klinische und morphologische Untersuchungen zur diagnostischen Abgrenzung. In: Klinische Wochenschrift. 1981 ; Vol. 59, No. 23. pp. 1313-1318.
@article{6aa7007f789f41b3afaf1fe2136723e6,
title = "Chronisch lymphatische Leuk{\"a}mie vom B-Zellen-Typ: Klinische und morphologische Untersuchungen zur diagnostischen Abgrenzung",
abstract = "Chronic lymphatic leukemia (CLL) was diagnosed in 71 patients based on clinical data. Most of the patients were in the stages 0, I and II, only 18{\%} were in the stages III and IV according to Rai. In all cases, the disease was characterized by an increased number of B lymphocytes (B-CLL). The B cells mostly expressed a weak fluorescence intensity when tested for membrane bound immunoglobulins (Ig). In accordance to that, the quantitative measurement of Ig in the serum revealed a decrease of one or more Ig classes in 72{\%} of the patients. No correlation existed between the number of B lymphocytes (and T lymphocytes) or the Ig concentration in the serum and the stage of the disease. To distinguish the CLL from related lymphoproliferative disorders, especially the immunocytic lymphoma, lymphnode biopsies were examined histologically and immunomorphologically for intracytoplasmic Ig. This examination confirmed the diagnosis of CLL in 33 out of 40 cases. Six lymphnodes were classified as immunocytic lymphoma of the lymphoplasmacytoid type. In three of the latter, the immunocytic lymphoma was clinically associated with decreased Ig concentrations in the serum. These findings emphasize that the clinically established diagnosis of CLL should be corroborated by immunomorphology.",
keywords = "B-cell proliferation, Chronic lymphatic leukemia, Hypogammaglobulinaemia, Immunocytic lymphoma, Immunomorphology",
author = "Schwarzmeier, {J. D.} and T. Radaszkiewicz and W. Graninger and F. Hofer and Paietta, {Elisabeth M.} and Ch Moser",
year = "1981",
month = "12",
doi = "10.1007/BF01711181",
language = "German",
volume = "59",
pages = "1313--1318",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "23",

}

TY - JOUR

T1 - Chronisch lymphatische Leukämie vom B-Zellen-Typ

T2 - Klinische und morphologische Untersuchungen zur diagnostischen Abgrenzung

AU - Schwarzmeier, J. D.

AU - Radaszkiewicz, T.

AU - Graninger, W.

AU - Hofer, F.

AU - Paietta, Elisabeth M.

AU - Moser, Ch

PY - 1981/12

Y1 - 1981/12

N2 - Chronic lymphatic leukemia (CLL) was diagnosed in 71 patients based on clinical data. Most of the patients were in the stages 0, I and II, only 18% were in the stages III and IV according to Rai. In all cases, the disease was characterized by an increased number of B lymphocytes (B-CLL). The B cells mostly expressed a weak fluorescence intensity when tested for membrane bound immunoglobulins (Ig). In accordance to that, the quantitative measurement of Ig in the serum revealed a decrease of one or more Ig classes in 72% of the patients. No correlation existed between the number of B lymphocytes (and T lymphocytes) or the Ig concentration in the serum and the stage of the disease. To distinguish the CLL from related lymphoproliferative disorders, especially the immunocytic lymphoma, lymphnode biopsies were examined histologically and immunomorphologically for intracytoplasmic Ig. This examination confirmed the diagnosis of CLL in 33 out of 40 cases. Six lymphnodes were classified as immunocytic lymphoma of the lymphoplasmacytoid type. In three of the latter, the immunocytic lymphoma was clinically associated with decreased Ig concentrations in the serum. These findings emphasize that the clinically established diagnosis of CLL should be corroborated by immunomorphology.

AB - Chronic lymphatic leukemia (CLL) was diagnosed in 71 patients based on clinical data. Most of the patients were in the stages 0, I and II, only 18% were in the stages III and IV according to Rai. In all cases, the disease was characterized by an increased number of B lymphocytes (B-CLL). The B cells mostly expressed a weak fluorescence intensity when tested for membrane bound immunoglobulins (Ig). In accordance to that, the quantitative measurement of Ig in the serum revealed a decrease of one or more Ig classes in 72% of the patients. No correlation existed between the number of B lymphocytes (and T lymphocytes) or the Ig concentration in the serum and the stage of the disease. To distinguish the CLL from related lymphoproliferative disorders, especially the immunocytic lymphoma, lymphnode biopsies were examined histologically and immunomorphologically for intracytoplasmic Ig. This examination confirmed the diagnosis of CLL in 33 out of 40 cases. Six lymphnodes were classified as immunocytic lymphoma of the lymphoplasmacytoid type. In three of the latter, the immunocytic lymphoma was clinically associated with decreased Ig concentrations in the serum. These findings emphasize that the clinically established diagnosis of CLL should be corroborated by immunomorphology.

KW - B-cell proliferation

KW - Chronic lymphatic leukemia

KW - Hypogammaglobulinaemia

KW - Immunocytic lymphoma

KW - Immunomorphology

UR - http://www.scopus.com/inward/record.url?scp=0019731582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019731582&partnerID=8YFLogxK

U2 - 10.1007/BF01711181

DO - 10.1007/BF01711181

M3 - Article

C2 - 6975856

AN - SCOPUS:0019731582

VL - 59

SP - 1313

EP - 1318

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 23

ER -